Please confirm that you would like to log out of Medscape.
If you log out, you will be required to enter your username and password the next time you visit.
Log outCancel
John M. Mandrola, MD Musings from Mandrola
Chief Cardiology Correspondent. Clinical Electrophysiologist, Baptist Medical Associates, Louisville, Kentucky
Trials & Fibrillations with John Mandrola
The Most Important Study From ESCIf you treat patients, no trial at ESC is more important, according to John Mandrola, MD. The results of FRAIL-AF demonstrate the value of humility in science and the practice of evidence-based medicine.
theheart.org on Medscape, September 1, 2023
ESC 2023AF Ablation in End-Stage HF: Too Good to Be True?Patients with AF and end-stage heart failure saw a dramatic early benefit from ablation. Some question the findings but others see a subset of patients for whom sinus rhythm makes a big difference.
theheart.org on Medscape, August 30, 2023
ESC 2023Pulsed Field Ablation for AF Underwhelming in ADVENT Pulsed field ablation did not live up to the hype and enthusiasm of European colleagues, according to this US-based electrophysiologist, but the results of ADVENT are likely sufficient for FDA approval.
theheart.org on Medscape, August 28, 2023
ESC 2023Supporting Evidence for a Common PracticeJohn Mandrola, MD, reviews BUDAPEST CRT from ESC 2023, which supports the practice of upgrading patients with pacing-induced heart failure to cardiac resynchronization therapy.
theheart.org on Medscape, August 27, 2023
ESC 2023Semaglutide in HFpEF Cleared a Low BarPatients with heart failure with preserved ejection fraction and obesity lost weight and felt better while taking semaglutide vs placebo, but was the bar for success set too low in STEP-HFpEF?
Who Decides What Is Medical Misinformation? A California law against COVID misinformation may have good intentions, but medicine is replete with consensus recommendations that end up being wrong.
Medscape, October 13, 2022
Why Is Vitamin D Hype So Impervious to Evidence?Low levels of vitamin D are linked to myriad health conditions, but supplements have never delivered in a randomized trial. Why aren't clinicians and patients persuaded by the data, asks John Mandrola, MD.
Medscape, February 17, 2022
This Doc Still Supports NP/PA Led Care … With CaveatsThe rise in nurse practitioner- and physician assistant-led care will not be undone, according to this doctor who sees it as a good thing as long as training and experience are not neglected.
